Guidelines currently recommend rapid door-to-balloon times (Ͻ90 min) for reperfusion with percutaneous coronary revascularization in ST-elevation myocardial infarction (STEMI). In this issue of Circulation, Bradley and colleagues report on a qualitative study using in-depth interviews with clinical and administrative staff at 11 hospitals that experienced outstanding improvement in door-to-balloon times from 1999 to 2002. The experiences of these hospitals suggest that innovative program development within interdisciplinary teams that includes specific goals, engages senior management, and provides detailed data feedback with a nonblaming, patient-focused approach can serve as a foundation for efforts to improve door-to-balloon times. See p 1079.
MAGNETIC RESONANCE IMAGING-GUIDED BALLOON ANGIOPLASTY OF COARCTATION OF THE AORTA: A PILOT STUDY, by Krueger et al.
Percutaneous intervention for congenital heart disease has become a major component of reparative therapies for many congenital cardiovascular abnormalities. These procedures are often long and repeated and have high radiation exposure. Magnetic resonance imaging (MRI) is a major imaging modality for preprocedure and postprocedure evaluation. In this issue, Krueger et al, in a small pilot study, describe successful interactive real-time MRI-guided percutaneous aortic coarctation intervention in 5 patients. The technique, results, safety requirements, and proximity to the traditional catheterization laboratory are detailed. The potential for interactive real-time MRI to guide invasive procedures is an important advance in this field. It should allow continuous monitoring of soft tissue structures during the intervention and significantly reduce radiation exposure. Further validation of this approach will be important to substantiate its role in percutaneous interventions. See p 1093.
CORRELATES AND LONG-TERM OUTCOMES OF ANGIOGRAPHICALLY PROVEN STENT THROMBOSIS WITH SIROLIMUS-AND PACLITAXEL-ELUTING STENTS, by Kuchulakanti et al.
In the drug-eluting stent era, stent thrombosis remains a serious procedural complication with significant adverse sequelae. It has been suggested that, as compared with bare metal stents, drugeluting stents pose a greater risk of stent thrombosis owing to delayed reendothelialization as well as inherent thrombogenicity despite optimal oral anticoagulation. Furthermore, stent thrombosis associated with drug-eluting stent implantation has been shown to occur both subacutely (Յ30 days) and late (Ͼ30 days), thereby shifting the time frame for which clinicians should maintain a heightened state of awareness for this complication. Patients who develop stent thrombosis frequently require repeat revascularization procedures and have an increased incidence of Q-wave and non-Q-wave myocardial infarction. In this issue of Circulation, Kuchulakanti et al analyze the clinical and procedural characteristics of patients with angiographically proven stent thrombosis and the influence of this complication on outcome at 6 months. See p 1108.
Visit http://circ.ahajournals.org:

Clinician Update
Inflammatory Biomarkers in Acute Coronary Syndromes: Part III: Biomarkers of Oxidative Stress and Angiogenic Growth Factors. See p e289.
